Chargement en cours...
Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases
Three patients, each of whom had required intensive open-ended antimicrobial therapy for control of the symptoms of chronic relapsing neurological Lyme disease and relapsing babesiosis, were able to discontinue treatment and remain clinically well for periods of observation of 6–23 months following...
Enregistré dans:
| Publié dans: | Antibiotics (Basel) |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6627205/ https://ncbi.nlm.nih.gov/pubmed/31151194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics8020072 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|